EcoR1 Capital, LLC Quant / Systematic

CIK: 0001587114 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value ($000): $563,229 (100.0% shares, 0.0% debt)

Holdings (36)

ALEXION PHARMACEUTICALS, INC 13.9%
Value ($000) $78,215 Shares 569,500 Est. Cost Unrealized
IRWD IRONWOOD PHARMACEUTICALS INC 12.6%
Value ($000) $70,869 Shares 3,753,635 Est. Cost $10.60 Unrealized +37.1%
ASSEMBLY BIOSCIENCES INC 10.8%
Value ($000) $60,776 Shares 2,943,164 Est. Cost $8.38 Unrealized
FIBROGEN INC 9.1%
Value ($000) $51,210 Shares 1,585,457 Est. Cost $32.10 Unrealized
GLPG GALAPAGOS NV SPON ADR 7.9%
Value ($000) $44,267 Shares 578,505 Est. Cost $58.59 Unrealized
ASND ASCENDIS PHARMA A S 7.3%
Value ($000) $41,157 Shares 1,482,600 Est. Cost $22.80 Unrealized
GILEAD SCIENCES INC 6.8%
Value ($000) $38,045 Shares 500,000 Est. Cost Unrealized
SGMO SANGAMO BIOSCIENCES INC 4.0%
Value ($000) $22,599 Shares 2,568,119 Est. Cost $6.42 Unrealized 0.0%
KURA KURA ONCOLOGY INC COM 3.4%
Value ($000) $18,913 Shares 2,033,622 Est. Cost $10.12 Unrealized -10.1%
TOCAGEN INC 3.2%
Value ($000) $18,074 Shares 1,502,373 Est. Cost $12.03 Unrealized
CTMX CYTOMX THERAPEUTICS INC 2.2%
Value ($000) $12,322 Shares 794,969 Est. Cost $13.16 Unrealized +14.5%
EDIT EDITAS MEDICINE INC COM 2.1%
Value ($000) $12,033 Shares 717,107 Est. Cost $18.02 Unrealized 0.0%
CASCADIAN THERAPEUTICS INC 2.0%
Value ($000) $11,145 Shares 3,000,000 Est. Cost $4.14 Unrealized
CRVS CORVUS PHARMACEUTICALS INC 1.7%
Value ($000) $9,741 Shares 805,000 Est. Cost $10.68 Unrealized 0.0%
VERTEX PHARMACEUTICALS INC 1.6%
Value ($000) $9,109 Shares 60,000 Est. Cost Unrealized
FATE FATE THERAPEUTICS INC 1.5%
Value ($000) $8,220 Shares 2,537,026 Est. Cost $3.66 Unrealized +4.7%
ATYR PHARMA INC 1.4%
Value ($000) $7,795 Shares 2,292,659 Est. Cost $2.92 Unrealized
OVASCIENCE INC 1.0%
Value ($000) $5,479 Shares 3,512,332 Est. Cost $1.87 Unrealized
ACRS ACLARIS THERAPEUTICS INC 0.9%
Value ($000) $5,030 Shares 185,472 Est. Cost $26.78 Unrealized +1.5%
KINDRED BIOSCIENCES INC 0.8%
Value ($000) $4,686 Shares 544,880 Est. Cost $7.10 Unrealized
TETRAPHASE PHARMACEUTICALS INC 0.8%
Value ($000) $4,516 Shares 633,400 Est. Cost $7.13 Unrealized
EDITAS MEDICINE INC COM 0.8%
Value ($000) $4,315 Shares 255,000 Est. Cost Unrealized
REGULUS THERAPEUTICS INC 0.6%
Value ($000) $3,656 Shares 3,709,144 Est. Cost $1.26 Unrealized
ACHILLION PHARMACEUTICALS INC 0.6%
Value ($000) $3,410 Shares 742,835 Est. Cost $4.59 Unrealized
NABRIVA THERAPEUTICS 0.5%
Value ($000) $2,775 Shares 264,773 Est. Cost $10.48 Unrealized
DICERNA PHARMACEUTICALS INC 0.4%
Value ($000) $2,435 Shares 767,992 Est. Cost $3.28 Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.4%
Value ($000) $2,186 Shares 874,447 Est. Cost $4.11 Unrealized
MINERVA NEUROSCIENCES INC 0.4%
Value ($000) $1,981 Shares 223,802 Est. Cost $8.85 Unrealized
BIOHAVEN PHARMACEUTICAL HLDG CO LTD 0.3%
Value ($000) $1,750 Shares 70,000 Est. Cost $25.00 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 0.2%
Value ($000) $1,199 Shares 23,300 Est. Cost $43.55 Unrealized +17.4%
CHEMOCENTRYX INC 0.2%
Value ($000) $1,104 Shares 118,000 Est. Cost $7.28 Unrealized
BMY BRISTOL MYERS SQUIBB CO 0.2%
Value ($000) $951 Shares 17,060 Est. Cost $39.73 Unrealized +0.4%
CLOVIS ONCOLOGY INC 0.2%
Value ($000) $936 Shares 10,000 Est. Cost $93.60 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 0.1%
Value ($000) $831 Shares 10,425 Est. Cost $63.91 Unrealized 0.0%
SEATTLE GENETICS INC 0.1%
Value ($000) $776 Shares 15,000 Est. Cost $51.73 Unrealized
ARATANA THERAPEUTICS INC 0.1%
Value ($000) $723 Shares 100,000 Est. Cost $7.23 Unrealized